Lantern Pharma's market cap is currently ―. The company's EPS TTM is $-1.472; its P/E ratio is -3.92; Lantern Pharma is scheduled to report earnings on April 30, 2024, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -4.19M	$ -3.16M	$ -4.75M	$ 4.70M	$ 610.61K
EBITDA	$ -4.18M	$ -3.16M	$ -4.74M	$ 4.71M	$ 608.03K
Net Income Common Stockholders	$ -4.19M	$ -3.16M	$ -4.75M	$ 4.70M	$ 685.29K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 41.30M	$ 44.93M	$ 48.49M	$ 52.08M	$ 55.74M
Total Assets	$ 43.65M	$ 47.77M	$ 51.43M	$ 55.46M	$ 58.84M
Total Debt	$ 234.47K	$ 274.53K	$ 313.86K	$ 260.22K	$ 52.89K
Net Debt	$ -41.07M	$ -44.65M	$ -48.18M	$ -51.82M	$ -55.68M
Total Liabilities	$ 2.74M	$ 2.36M	$ 3.17M	$ 2.93M	$ 2.80M
Stockholders Equity	$ 40.91M	$ 45.41M	$ 48.26M	$ 52.58M	$ 56.04M
Cash Flow	-
Free Cash Flow	$ -3.39M	$ -3.62M	$ -3.63M	$ -3.73M	$ -2.68M
Operating Cash Flow	$ -3.39M	$ -3.61M	$ -3.63M	$ -3.72M	$ -2.67M
Investing Cash Flow	$ 256.18K	$ 231.73K	$ -457.24K	$ -960.88K	$ 602.86K
Financing Cash Flow	$ -500.00K	-	-	-	-

Currency in USD

Lantern Pharma Earnings and Revenue History

Income Statement >

Lantern Pharma Debt to Assets

Balance Sheet >

Lantern Pharma Cash Flow

Cash Flow >

Lantern Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing